Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TBP

Tetra Bio Pharma (TBP)

Tetra Bio Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:TBP
DateTimeSourceHeadlineSymbolCompany
03/07/20237:01AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSX:TBPTetra Bio Pharma Inc
03/07/20236:59AMPR Newswire (Canada)IIROC Trading Halt - TBPTSX:TBPTetra Bio Pharma Inc
02/10/20235:27PMPR Newswire (Canada)Tetra Bio-Pharma Announces Listing to OTCPink MarketTSX:TBPTetra Bio Pharma Inc
02/10/20235:27PMPR Newswire (US)Tetra Bio-Pharma Announces Listing to OTCPink MarketTSX:TBPTetra Bio Pharma Inc
12/22/20226:41AMPR Newswire (Canada)REDUVO™ Marketing Approval on the Right PathTSX:TBPTetra Bio Pharma Inc
12/22/20226:41AMPR Newswire (US)REDUVO™ Marketing Approval on the Right PathTSX:TBPTetra Bio Pharma Inc
12/06/20226:00AMPR Newswire (US)Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with FavipiravirTSX:TBPTetra Bio Pharma Inc
12/06/20226:00AMPR Newswire (Canada)Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with FavipiravirTSX:TBPTetra Bio Pharma Inc
11/29/20226:00AMPR Newswire (US)Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003TSX:TBPTetra Bio Pharma Inc
11/29/20226:00AMPR Newswire (Canada)Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003TSX:TBPTetra Bio Pharma Inc
11/18/202211:23AMPR Newswire (Canada)Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug SubmissionTSX:TBPTetra Bio Pharma Inc
11/18/202211:23AMPR Newswire (US)Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug SubmissionTSX:TBPTetra Bio Pharma Inc
10/27/202212:57PMPR Newswire (US)Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
10/27/202212:57PMPR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
10/11/20226:42AMPR Newswire (US)Tetra and Prepaire Jointly Apply to BARDA for FundingTSX:TBPTetra Bio Pharma Inc
10/11/20226:42AMPR Newswire (Canada)Tetra and Prepaire Jointly Apply to BARDA for FundingTSX:TBPTetra Bio Pharma Inc
09/08/20226:44AMPR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
09/08/20226:44AMPR Newswire (US)Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
09/06/20228:28AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TBPTSX:TBPTetra Bio Pharma Inc
09/06/20228:27AMPR Newswire (Canada)IIROC Trade Resumption - TBPTSX:TBPTetra Bio Pharma Inc
09/06/20228:13AMPR Newswire (Canada)Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 PatientsTSX:TBPTetra Bio Pharma Inc
09/06/20228:13AMPR Newswire (US)Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 PatientsTSX:TBPTetra Bio Pharma Inc
09/06/20227:43AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSX:TBPTetra Bio Pharma Inc
09/06/20227:41AMPR Newswire (Canada)IIROC Trading Halt - TBPTSX:TBPTetra Bio Pharma Inc
08/11/20229:19PMPR Newswire (US)Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
08/11/20229:19PMPR Newswire (Canada)Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
08/10/20225:30AMPR Newswire (Canada)Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral InfectionsTSX:TBPTetra Bio Pharma Inc
08/10/20225:30AMPR Newswire (US)Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral InfectionsTSX:TBPTetra Bio Pharma Inc
07/12/20226:30AMPR Newswire (Canada)Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription DrugTSX:TBPTetra Bio Pharma Inc
07/12/20226:30AMPR Newswire (US)Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription DrugTSX:TBPTetra Bio Pharma Inc
 Showing the most relevant articles for your search:TSX:TBP